Silence Therapeutics PLC(SLN) - 2020 Q2 - Earnings Call Transcript

Silence Therapeutics Plc (OTC:SLNCF) Q2 2020 Results Conference Call September 14, 2020 8:00 AM ET Company Participants Gem Hopkins - Head, IR and Corporate Communications Iain Ross - Chairman Mark Rothera - President & CEO Giles Campion - Head of R&D and Chief Medical Officer Rob Quinn - Chief Financial Officer Conference Call Participants Patrick Trucchio - H.C. Wainwright Jens Lindqvist - Investec Miles Dixon - Peel Hunt Gem Hopkins Good morning and good afternoon, and thank you for joining us for the Si ...